Vericel (VCEL) Short-term Investments (2018 - 2026)
Vericel (VCEL) reported Short-term Investments of $36.0 million for Q1 2026, down 8.54% on a YoY basis from $39.4 million in Q1 2025, and down 3.64% sequentially from $37.4 million in Q4 2025.
Vericel (VCEL) Short-term Investments (2018 - 2026) Analysis & Trends
Vericel (VCEL) has 9 years of Short-term Investments data on file, last reported at $36.0 million in Q1 2026.
- For the quarter ending Q1 2026, Short-term Investments fell 8.54% year-over-year to $36.0 million; the trailing twelve-month figure through Mar 2026 stood at $36.0 million (down 8.54% YoY), and the FY2025 full-year result was $37.4 million, up 255.28% from the prior year.
- Short-term Investments slipped to $36.0 million in Q1 2026, from $37.4 million in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $68.5 million in Q4 2022 to a low of $10.5 million in Q4 2024.
- A 5-year average of $37.7 million and a median of $37.4 million in 2025 frame the typical range for Short-term Investments.
- Across the five-year window, Short-term Investments sank 74.04% in 2023 and surged 255.28% in 2025, its largest moves.
- Tracing VCEL's Short-term Investments over 5 years: stood at $68.5 million in 2022, then slumped by 74.04% to $17.8 million in 2023, then slumped by 40.78% to $10.5 million in 2024, then surged by 255.28% to $37.4 million in 2025, then fell by 3.64% to $36.0 million in 2026.
- Business Quant data shows VCEL's Short-term Investments at $36.0 million in Q1 2026, $37.4 million in Q4 2025, and $35.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Vericel | 2.30 Bn | 2.15 Bn | 49.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.05 Mn |
| Dec 31, 2025 | 37.41 Mn |
| Sep 30, 2025 | 34.98 Mn |
| Jun 30, 2025 | 36.35 Mn |
| Mar 31, 2025 | 39.41 Mn |
| Dec 31, 2024 | 10.53 Mn |
| Sep 30, 2024 | 16.67 Mn |
| Jun 30, 2024 | 25.56 Mn |
| Mar 31, 2024 | 47.71 Mn |
| Dec 31, 2023 | 17.78 Mn |
| Sep 30, 2023 | 23.09 Mn |
| Jun 30, 2023 | 54.81 Mn |
| Mar 31, 2023 | 57.44 Mn |
| Dec 31, 2022 | 68.47 Mn |
| Sep 30, 2022 | 45.72 Mn |
| Jun 30, 2022 | 44.64 Mn |
| Mar 31, 2022 | 44.89 Mn |
| Dec 31, 2021 | 35.07 Mn |
| Sep 30, 2021 | 43.74 Mn |
| Jun 30, 2021 | 39.21 Mn |